Market Recap — March 31, 2026

Shareholders Approve Master Transaction Agreement, Company to Go Private

McCormick Finalizes Transformative $44.8B Merger with Unilever Foods, Incurring Substantial Debt and Dilution

Streamex Reports Catastrophic $462.76M Net Loss, Zero Revenue in 2025 10-K

Shareholders Approve Zijin Gold Acquisition; Company Reports Record 2025 Production & Strong Growth

Auditor Issues Going Concern Warning Amid Widening Losses and Nasdaq Delisting Threat

Apellis Board Unanimously Recommends Biogen's $5.6B Acquisition Offer at $41/Share Plus CVR

Mobivity Holdings Completes Sale of Substantially All Assets, Receives $5.1M Cash and $13.3M in Equity

Faraday Future Reports Deepening Losses, Going Concern Doubt, and Nasdaq Delisting Notice for 2025

Vynleads Discloses Going Concern Doubt, Zero Revenue, and Material Weakness in Annual Report

Direct Digital Holdings Reports Dire 2025 Results, Going Concern Warning, and Massive Dilution Risk from $100M ATM Program

Apellis to be Acquired by Biogen for $5.6 Billion in Cash and CVRs

Biogen Launches Tender Offer to Acquire Apellis for $41/Share Cash Plus CVRs, Valuing Company at $5.6 Billion

RA Capital Funds, Directors Buy $8.76M in Mineralys Therapeutics Stock

Director Buys $3.72M in QFIN Shares and Closes Bearish Options Position Amidst Lows

Director Lu Hongbo Buys $1.5M in Zenas BioPharma Public Offering, Signaling Confidence

10% Owner Eric L. Oliver Boosts Stake with $701K Share Purchase

Immunome CEO Buys Over $500K in Open Market Shares

CEO Stenberg Makes Significant Open Market Purchase and Exercises Options

Chairman of Advisor Herzfeld Buys $46K in Company Stock

Controlling Shareholder Randal J. Kirk Sells $15.75 Million in Precigen Stock

Chairman and CEO Sells $15 Million in Stock Amidst Highs

Director Sells $9.9 Million in Assured Guaranty Stock

Director Lawrence Bryan H. Sells Additional $3.05M in Ramaco Resources Stock

10% Owner Sells Over $494K in Clene Inc. Stock Amidst Going Concern Doubts

10% Owner Sells Over $286K in HG Holdings Stock

Polyrizon CEO Sells $42.5K in Shares Amidst Recent Dilution Disclosures

Shareholders Approve Master Transaction Agreement, Company to Go Private

McCormick Finalizes Transformative $44.8B Merger with Unilever Foods, Incurring Substantial Debt and Dilution

Streamex Reports Catastrophic $462.76M Net Loss, Zero Revenue in 2025 10-K

Mobivity Holdings Completes Sale of Substantially All Assets, Receives $5.1M Cash and $13.3M in Equity

Apellis to be Acquired by Biogen for $5.6 Billion in Cash and CVRs

ZeroStack Announces Transformational Acquisition of Texas Blocker and Major Debt Settlement

Sharps Technology Reports Catastrophic $282.5M Net Loss, Minimal Revenue in 2025 10-K

Beyond Meat Reports Steep Q4 Revenue Decline, Misses Estimates, Delays 10-K, and Loses S-3 Eligibility

Co-Diagnostics Reports Staggering $35.25/Share Loss for 2025, Revenue Plummets

Unilever Confirms $44.8B Food Business Merger with McCormick, Creating $65B Giant

Director-Affiliated Fund Files Intent to Sell $242.6M in Cogent Biosciences Shares

Major 10% Shareholder Files Intent to Sell $63.5M in MoonLake Immunotherapeutics Stock

Major Shareholder Elliott Investment Management Files Intent to Sell $127.5M in Triple Flag Precious Metals Shares

Executive Chairman Edward Stack Files Intent to Sell $41.6 Million in DKS Shares

Former Board Member Files Intent to Sell $149K in Shares Amid Going Concern Warning

Affiliate Files Intent to Sell $11.35 Million in Fundrise Innovation Fund Shares

Officer Brian Cree Files Second Form 144 to Sell $929K in Stock Amid Leadership Transition